| Authors: |
Ravani LV; Department of Medicine, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, 01246-903, Brazil. lis.ravani@fm.usp.br., Wander SA; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, USA., Kok M; Divisions of Medical Oncology, Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., McCann K; Oncology Department, Los Angeles Medical Center, University of California, Los Angeles, California, 90095, USA., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Barroso-Sousa R; Hospital Brasília, Rede Américas, Brasília, DF, Brazil., Lustberg M; Medical Oncology, Yale Cancer Center, Yale University, New Haven, USA., Bines J; Oncology Department, Instituto Nacional de Cancer, Rio de Janeiro, Brazil., Michelon I; Division of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, USA., Testa L; Oncology Department, Instituto Do Câncer Do Estado de São Paulo (ICESP), São Paulo, Brazil., Wang M; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, USA., Deng D; Department of Public Health Sciences, Penn State University College of Medicine, Hershey, USA., Colombo Bonadio R; Oncology Department, Instituto D'Or de Pesquisa E Ensino (IDOR), São Paulo, Brasil. |
